As the most well-known analytical tool, the thermometer has been extended to the field of biological analysis based on the photothermal effect. Herein, isoniazide modified Ag nanoparticles were prepared as nanolabels to build an immunoassay. The nanoparticles were characterized by transmission electron microscope (TEM), dynamic laser scattering (DLS), X-ray powder diffraction (XRD), and Fourier transform infrared (FT-IR). When the target protein was present, the sandwich immunoassay was developed and the photothermal reaction was triggered by isoniazide modified Ag nanoparticles. As a reducing agent, isoniazide is used to transform phosphomolybdic acid hydrate into molybdenum blue solution. And molybdenum blue had good photothermal stability and high photothermal conversion efficiency. The temperature variation of molybdenum blue solution showed a positive correlation with the concentration of carcinoembryonic antigen (CEA). Thus, the target protein of CEA was quantitative detection by thermometer. The linear response range is 0.1 ng mL to 40 ng mL, and the detection limit is 0.08 ng mL. Moreover, the proposed protocol had satisfactory selectivity, accuracy, and reproducibility.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ab.2023.115370 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Isoniazid Preventive Therapy Adherence and Its Predictors Among Soldiers on HIV Antiretroviral Therapy at a General Military Hospital in Uganda.
HIV AIDS (Auckl)
November 2024
Department of Medicine, Makerere University, Kampala, Uganda.
Background: Uganda faces a significant dual challenge with tuberculosis (TB), ranking among these countries most affected by the disease worldwide. The World Health Organization (WHO) recommends isoniazid preventive therapy (IPT) for managing latent TB. However, the adherence to IPT in military settings remains under-explored in Uganda.
View Article and Find Full Text PDFStructural Studies on Mycobacterial NudC Reveal a Class of Zinc Independent NADH Pyrophosphatase.
J Mol Biol
December 2024
State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address:
Article Synopsis
- * The study focuses on NudC, an enzyme from M. abscessus, which is resistant to isoniazid, and explores its structure and function through various forms of crystal structures.
- * The findings reveal a unique variant of NudC that could help design new inhibitors for treating mycobacterial infections, particularly in combination with existing antibiotics like isoniazid or ethionamide.
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.
PLOS Glob Public Health
October 2024
Child Health and Development Center, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Three months of isoniazid-rifapentine (3HP) is being scaled up for tuberculosis (TB) preventive treatment (TPT) among people living with HIV (PLHIV) in high-burden settings. More evidence is needed to identify factors influencing successful 3HP delivery. We conducted a qualitative assessment of 3HP delivery nested within the 3HP Options Trial, which compared three optimized strategies for delivering 3HP: facilitated directly observed therapy (DOT), facilitated self-administered therapy (SAT), and patient choice between facilitated DOT and facilitated SAT at the Mulago HIV/AIDS clinic in Kampala, Uganda.
View Article and Find Full Text PDFA rapid and simple modified nitrate reductase assay for testing first and second-line antituberculosis drug susceptibilities in Mycobacterium tuberculosis isolates.
Diagn Microbiol Infect Dis
December 2024
Faculty of Health Sciences Research Laboratory, Tuberculosis Research Unit, Akdeniz University, Antalya, Türkiye; Faculty of Health Sciences, Department of Nutrition and Dietetics, Antalya, Türkiye; Department of Medical, Biotechnology, Institute of Health Sciences, Akdeniz University, Antalya, Türkiye. Electronic address:
In this study, we developed a modified NRA (MONRA) to determine the first and second-line drug susceptibilities of 5 reference ATCC strains and 42 clinical M. tuberculosis isolates. Unlike conventional NRA, which is often performed in solid media or 7H9 broth, the MONRA is performed in a different medium, AYC.
View Article and Find Full Text PDFHigh-Dose Rifampicin for 3 Months after Culture Conversion for Drug-Susceptible Pulmonary Tuberculosis.
Tuberc Respir Dis (Seoul)
January 2025
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Article Synopsis
- - The study investigated if a shorter, high-dose rifampicin treatment for tuberculosis is as effective as the standard 6-month regimen.
- - A total of 76 participants were enrolled, but the results showed a higher percentage of unfavorable outcomes in the investigational group compared to the control group, indicating the shorter regimen was not non-inferior.
- - Despite failing to prove non-inferiority, the shorter regimen did have a similar safety profile compared to the standard treatment.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!